We are live on ! Find out more

Progyny

PGNY

Market cap $1.99B

25.94 USD

-0.67

2.52%

At close Updated Sep 4, 4:00 PM EDT

Pre-market

After hours

25.94

0.00

0%

1 day

-2.52%

5 days

-0.15%

1 month

-17.6%

3 months

1.81%

6 months

45.81%

Year to date

0.78%

1 year

10.1%

5 years

-55.91%

10 years

62.74%

About: Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.

Employees: 856

Healthcare Healthcare Plans

News

Positive

Neutral

Negative

Sentiment 3-Months

Positive 52.6%

Neutral 42.1%

Negative 5.3%

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

NEW YORK, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its Chief Financial Officer Mark Livingston will present at the Wells Fargo 21st Annual Healthcare Conference in Boston, MA on Tuesday, September 8, 2026, at 11:00 a.m. ET.

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Zacks Investment Research

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

MNDY, MTCH, PGNY and WK make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Bet on These 4 Top-Performing Liquid Stocks to Maximize Returns

Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook

Progyny NASDAQ: PGNY CEO Pete Anevski said the company expects member engagement and utilization to rebound following a more pronounced summer seasonal slowdown, while early renewal and new-client commitments have increased management's confidence in its outlook for the remainder of the year.

Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook

Zacks Investment Research

Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks

IVZ, HUBS, HNGE and PGNY make the cut as the top liquid stocks, each boasting strong liquidity, growth attributes and operational efficiency.

Boost Your Portfolio Returns With These 4 Top-Ranked Liquid Stocks

The Motley Fool

Why Progyny Stock Plunged, Then Gradually Recovered Today

Progyny's sales and adjusted earnings per share grew by 5% and 15% in the second quarter. However, management's conservative guidance for 7% to 11% revenue growth in Q3 worried the market.

Why Progyny Stock Plunged, Then Gradually Recovered Today

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

NEW YORK, Aug. 07, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced that its CEO Pete Anevski will present at the Canaccord Genuity 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026, at 3:30 p.m. ET.

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny Q2 Earnings Call Highlights

Progyny NASDAQ: PGNY reported record quarterly revenue, gross profit and adjusted EBITDA for the second quarter of 2026, while management said early sales commitments and client-retention activity have positioned the company favorably for the 2027 selling season.

Progyny Q2 Earnings Call Highlights

Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript

Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript

Progyny, Inc. (PGNY) Q2 2026 Earnings Call Transcript

Zacks Investment Research

Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Progyny (PGNY) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Progyny (PGNY) Reports Q2 Earnings: What Key Metrics Have to Say

Zacks Investment Research

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

Progyny (PGNY) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.51 per share. This compares to earnings of $0.48 per share a year ago.

Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates

See News Rankings

Price charts implemented using Lightweight Charts™